SG11201912243PA - Methods and compositions for treating a bleeding event in a subject having hemophilia - Google Patents

Methods and compositions for treating a bleeding event in a subject having hemophilia

Info

Publication number
SG11201912243PA
SG11201912243PA SG11201912243PA SG11201912243PA SG11201912243PA SG 11201912243P A SG11201912243P A SG 11201912243PA SG 11201912243P A SG11201912243P A SG 11201912243PA SG 11201912243P A SG11201912243P A SG 11201912243PA SG 11201912243P A SG11201912243P A SG 11201912243PA
Authority
SG
Singapore
Prior art keywords
hemophilia
compositions
treating
subject
methods
Prior art date
Application number
SG11201912243PA
Other languages
English (en)
Inventor
Akin Akinc
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of SG11201912243PA publication Critical patent/SG11201912243PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG11201912243PA 2017-07-10 2018-07-10 Methods and compositions for treating a bleeding event in a subject having hemophilia SG11201912243PA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762530518P 2017-07-10 2017-07-10
US201762599223P 2017-12-15 2017-12-15
US201862614111P 2018-01-05 2018-01-05
US201862673424P 2018-05-18 2018-05-18
PCT/US2018/041400 WO2019014187A1 (en) 2017-07-10 2018-07-10 METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT WITH HEMOPHILIA

Publications (1)

Publication Number Publication Date
SG11201912243PA true SG11201912243PA (en) 2020-01-30

Family

ID=63036452

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912243PA SG11201912243PA (en) 2017-07-10 2018-07-10 Methods and compositions for treating a bleeding event in a subject having hemophilia

Country Status (13)

Country Link
US (2) US20200163987A1 (sr)
EP (1) EP3651852A1 (sr)
JP (2) JP2020530442A (sr)
KR (1) KR20200026960A (sr)
CN (1) CN111093771A (sr)
AU (1) AU2018301801A1 (sr)
BR (1) BR112020000400A2 (sr)
CA (1) CA3069150A1 (sr)
CO (1) CO2020001354A2 (sr)
IL (1) IL271646A (sr)
SG (1) SG11201912243PA (sr)
UY (1) UY37803A (sr)
WO (1) WO2019014187A1 (sr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023531679A (ja) 2020-06-22 2023-07-25 ジェンザイム・コーポレーション 血友病を処置するための方法および組成物
WO2022076835A1 (en) * 2020-10-09 2022-04-14 Dyax Corp. Methods and apparatuses for modeling adamts13 and von willebrand factor interactions
WO2022120292A1 (en) * 2020-12-06 2022-06-09 Genzyme Corporation Treatment of hemophilia with fitusiran
WO2022120291A1 (en) * 2020-12-06 2022-06-09 Genzyme Corporation Treatment of hemophilia with fitusiran
TW202342065A (zh) 2021-12-22 2023-11-01 美商健臻公司 治療血友病的方法和組成物
US20240000744A1 (en) 2022-06-08 2024-01-04 Genzyme Corporation Treatment of Hemophilia with Fitusiran
WO2023240193A2 (en) 2022-06-08 2023-12-14 Genzyme Corporation Treatment of hemophilia with fitusiran in pediatric patients
WO2024094699A1 (en) 2022-10-31 2024-05-10 Sanofi Container holder and drug delivery device comprising the container holder
WO2024094700A1 (en) 2022-10-31 2024-05-10 Sanofi Method for assembling an assembly for a drug delivery device and drug delivery device.
WO2024094701A1 (en) 2022-10-31 2024-05-10 Sanofi Assembly for a drug delivery device
WO2024094702A1 (en) 2022-10-31 2024-05-10 Sanofi Device body for a drug delivery device, assembly for a drug delivery device and drug delivery device
WO2024094706A1 (en) 2022-10-31 2024-05-10 Sanofi Audible indicator, indicator holder and method of assembling an audible indicator
WO2024094705A1 (en) 2022-10-31 2024-05-10 Sanofi Drug delivery device having a two-part user indicator
WO2024094707A1 (en) 2022-10-31 2024-05-10 Sanofi Drug delivery device with feedback element and method for providing a user of a drug delivery device feedback regarding a dose dispensing process
WO2024094703A1 (en) 2022-10-31 2024-05-10 Sanofi Plunger for expelling a drug, drug delivery device, rear sub-assembly and corresponding methods
WO2024094698A1 (en) 2022-10-31 2024-05-10 Sanofi Front sub-assembly for a drug delivery device
WO2024094704A1 (en) 2022-10-31 2024-05-10 Sanofi Arrangement for a drug delivery device, drug delivery device and method for assembly
WO2024097190A1 (en) 2022-11-02 2024-05-10 Genzyme Corporation Systems and methods for modeling thrombin-antithrombin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009284393B2 (en) * 2008-08-22 2014-09-25 Takeda Pharmaceutical Company Limited Methods for treating bleeding disorders
WO2015175510A1 (en) * 2014-05-12 2015-11-19 Alnylam Pharmaceuticals, Inc. Methods and compositions for treating a serpinc1-associated disorder
WO2016085852A1 (en) * 2014-11-24 2016-06-02 Alnylam Pharmaceuticals, Inc. Tmprss6 irna compositions and methods of use thereof
IL259795B2 (en) * 2015-12-07 2024-04-01 Genzyme Corp Methods and preparations for the treatment of diseases related to SERPINC1

Also Published As

Publication number Publication date
EP3651852A1 (en) 2020-05-20
CN111093771A (zh) 2020-05-01
US20200163987A1 (en) 2020-05-28
KR20200026960A (ko) 2020-03-11
WO2019014187A1 (en) 2019-01-17
JP2020530442A (ja) 2020-10-22
US20230158058A1 (en) 2023-05-25
BR112020000400A2 (pt) 2020-07-14
AU2018301801A1 (en) 2020-02-06
RU2020105876A3 (sr) 2021-11-16
CO2020001354A2 (es) 2020-05-29
CA3069150A1 (en) 2019-01-17
RU2020105876A (ru) 2021-08-10
UY37803A (es) 2019-02-28
IL271646A (en) 2020-02-27
JP2023123756A (ja) 2023-09-05
TW201920670A (zh) 2019-06-01

Similar Documents

Publication Publication Date Title
IL271646A (en) Methods and compounds for the treatment of a bleeding event in a hemophilia patient
IL245778B (en) Methods and preparations for the treatment of hemophilia
HK1256602A1 (zh) 用於治療翼狀胬肉的組合物和方法
HK1245632A1 (zh) 包含癌症干性抑制劑的組合物和用於治療癌症的免疫治療劑
HK1248590A1 (zh) 用於治療貧血的組合物和方法
PT3189074T (pt) Composições e métodos para tratar e prevenir a inflamação
HK1258696A1 (zh) 治療或預防皮膚障礙的新型組合物和方法
PT3261644T (pt) Composições e métodos para tratar a degradação retinal
PL3280423T3 (pl) Kompozycje i sposoby do synergistycznego leczenia glikokaliksu
SG11201508297YA (en) Compositions and methods for treating and preventing macular degeneration
IL271464A (en) NK-1 antagonist compositions and methods for use in the treatment of depression
HK1258371A1 (zh) 止血組合物和使用止血組合物的止血方法
EP3356598A4 (en) COMPOSITIONS AND METHOD FOR TREATING FILLER IN PAPER MANUFACTURE
IL261010B (en) Compositions and methods for treating chronic wounds
ZA201605109B (en) Compositions and methods for treating neutropenia
HK1256167A1 (zh) 用於治療或預防癌症和神經疾病的包括15-hepe的組合物
ZA201802268B (en) Methods and compositions for preventing or treating cancer
MX2018004632A (es) Metodos y composiciones para el tratamiento de una lesion cerebral traumatica.
IL272945A (en) Local preparations and methods of treatment
IL257407A (en) Compositions and methods for treating wounds
EP3429563A4 (en) COMPOSITIONS AND METHODS FOR TREATING FORCED BEHAVIOR IN ONE PERSON
GB201716239D0 (en) Compositions and methods for treating pseudoaneurysm
EP3397271A4 (en) COMPOSITIONS AND METHOD FOR TREATING RETINOPATHY
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201509272D0 (en) Microparticles and composition